Downstream Processing Featured Articles

  1. Aeras Signs Agreement With GSK To Jointly Advance TB Vaccine 10/10/2012

    Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK’s proprietary M72 antigen and AS01E adjuvant.

  2. New 1.3-Micron Kinetex Core-Shell Media Delivers Superior UHPLC Performance 1/15/2013

    Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of 1.3-micron UHPLC columns to its Kinetex core-shell product line.

  3. Saving Patients From The Needle Boosts Drug Delivery Company Revenues: Report 2/20/2013

    Led by needle-free delivery systems the advanced implantable/injectible drug delivery market reached revenues of $13.3 billion in 2012, according to their recently published report Injectable, Implantable and Needle-Free Drug Delivery Systems.

  4. Paired Genes In Stem Cells Shed New Light On Gene Organization And Regulation 2/4/2013

    Whitehead Institute researchers have determined that DNA transcription, the process that produces messenger RNA (mRNA) templates used in protein production, also runs in the opposite direction along the DNA to create corresponding long noncoding RNAs (lncRNAs). By Nicole Giese Rura

  5. Roche Medicine Avastin Receives EU Approval For The Treatment Of Women With Recurrent, Platinum-Sensitive Ovarian Cancer 10/31/2012

    Roche announced recently that the European Commission (EC) has approved Avastin (bevacizumab) in combination with standard chemotherapy (carboplatin and gemcitabine) as a treatment for women with first recurrence of platinum-sensitive ovarian cancer.

  6. Galapagos Announces GSK2586184 JAK1 Molecule Progresses To Phase 2 Studies 2/5/2013

    Galapagos NV (Euronext: GLPG) announced today that GlaxoSmithKline plan to initiate Phase 2 studies with GSK2586184 (formerly GLPG0778) in systemic lupus erythematosus (SLE) and chronic plaque psoriasis.

  7. Rare Cancers Yield Potential Source Of Tumor Growth 9/17/2012

    Researchers at the National Institutes of Health have discovered a genetic mutation that appears to increase production of red blood cells in tumors.

  8. Theraclone Sciences Secures $14M In Additional Financing 3/25/2013

    Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, recently announced a $14M financing. $8M in equity is committed from existing investors ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures, Versant Ventures and Zenyaku Kogyo in a Series B Extension, bringing the total round to $50M.

  9. Roche Invests In Stratos Genomics For Further Development Of The 'Sequencing By Expansion' (SBX) Method Applied To Single Molecule Nanopore Sequencing 6/26/2014

    Roche announced recently, it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using protein nanopores.

  10. BARDA Continues Novavax' Influenza Vaccine Programs Following In-Process Review 1/24/2013

    Novavax, Inc. (Nasdaq:NVAX) today announced that the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) has completed an In-Process Review (IPR) of Novavax' contract covering the company's recombinant virus-like particle (VLP) vaccine candidates for pandemic and seasonal influenza.